American Journal of Roentgenology, Vol 157, 731-739, Copyright © 1991 by American Roentgen Ray Society

ARTICLES

Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging

K Wernecke, E Rummeny, G Bongartz, P Vassallo, D Kivelitz, W Wiesmann, PE Peters, B Reers, M Reiser and W Pircher
Institute of Clinical Radiology, University of Munster Medical School, Germany.

To evaluate the sensitivity of sonography, CT, and MR imaging in the detection of hepatic masses in carcinoma patients, we conducted a prospective study of 75 consecutive patients with gastrointestinal tumors who were admitted for surgical resection of the primary tumor. Sonography was performed with convex transducers of 3.5 and 5.0 MHz. Three noninvasive CT techniques were used: unenhanced CT scans, the incremental bolus dynamic scanning technique, and delayed scanning 4-6 hr after bolus injection of 60 g of iodine. MR images (1.5 T) were acquired as presaturated T1- and T2-weighted spin-echo sequences and as breath-holding fast low-angle shot (FLASH) 60 degrees and FLASH 15 degrees sequences. As it is difficult to distinguish benign from malignant masses solely on the basis of morphologic criteria, the techniques for each imaging method were designed to detect and not to characterize hepatic lesions. Each examination was interpreted blindly, and the results were compared with surgical findings, intraoperative sonography, and biopsy of the liver as the gold standard. All focal hepatic masses verified at surgery, malignant or benign, were included in the analysis. Sixty-five (68%) of 95 focal hepatic masses were detected by CT, 60 lesions (63%) by MR, and 50 lesions (53%) by sonography. Although lesions 1-2 cm were shown almost equally well by CT and MR (74% and 77%, respectively), the detection rate of smaller lesions (less than 1.0 cm) decreased more drastically with MR (31%) than with CT (49%). Sonography had a sensitivity of only 20% with the smaller lesions. All imaging techniques had a sensitivity of 100% for focal hepatic masses larger than 2.0 cm. Our results show that CT has a higher overall sensitivity (68%) than MR and sonography for the detection of focal hepatic masses. When the results of the three procedures are combined, the overall sensitivity is 77%. This is unsatisfactorily low, as CT and MR have a size threshold of about 1.0 cm and are relatively unreliable for the detection of smaller lesions.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Wiering, T. J. M. Ruers, P. F. M. Krabbe, H. M. Dekker, and W. J. G. Oyen Comparison of Multiphase CT, FDG-PET and Intra-Operative Ultrasound in Patients with Colorectal Liver Metastases Selected for Surgery Ann. Surg. Oncol., February 1, 2007; 14(2): 818 - 826. [Abstract] [Full Text] [PDF]

				S. Bipat, M. S. van Leeuwen, E. F. I. Comans, M. E. J. Pijl, P. M. M. Bossuyt, A. H. Zwinderman, and J. Stoker Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis--Meta-analysis Radiology, October 1, 2005; 237(1): 123 - 131. [Abstract] [Full Text] [PDF]

				S. H. Kim, J. M. Lee, J. Y. Lee, J. K. Han, S. K. An, C. J. Han, K. H. Lee, S. S. Hwang, and B. I. Choi Value of Contrast-Enhanced Sonography for the Characterization of Focal Hepatic Lesions in Patients with Diffuse Liver Disease: Receiver Operating Characteristic Analysis Am. J. Roentgenol., April 1, 2005; 184(4): 1077 - 1084. [Abstract] [Full Text] [PDF]

				G. S. Gazelle, P. M. McMahon, M. T. Beinfeld, E. F. Halpern, and M. C. Weinstein Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection Radiology, December 1, 2004; 233(3): 729 - 739. [Abstract] [Full Text] [PDF]

				S.M. M. de Castro, E.H. B. M. Tilleman, O.R. C. Busch, O.M. van Delden, J.S. Lameris, T.M. van Gulik, H. Obertop, and D.J. Gouma Diagnostic Laparoscopy for Primary and Secondary Liver Malignancies: Impact of Improved Imaging and Changed Criteria for Resection Ann. Surg. Oncol., May 1, 2004; 11(5): 522 - 529. [Abstract] [Full Text] [PDF]

				C F Dietrich, A Ignee, J Trojan, C Fellbaum, and G Schuessler Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A Gut, March 1, 2004; 53(3): 401 - 405. [Abstract] [Full Text] [PDF]

				C. D. Frate, C. Zuiani, V. Londero, G. Como, M. Bazzocchi, K. Mortele, and P. R. Ros Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases Am. J. Roentgenol., May 1, 2003; 180(5): 1339 - 1346. [Abstract] [Full Text] [PDF]

				T. Albrecht, M. J. K. Blomley, P. N. Burns, S. Wilson, C. J. Harvey, E. Leen, M. Claudon, F. Calliada, J.-M. Correas, M. LaFortune, et al. Improved Detection of Hepatic Metastases with Pulse-Inversion US during the Liver-specific Phase of SHU 508A: Multicenter Study Radiology, May 1, 2003; 227(2): 361 - 370. [Abstract] [Full Text] [PDF]

				C. Del Frate, M. Bazzocchi, K. J. Mortele, C. Zuiani, V. Londero, G. Como, R. Zanardi, and P. R. Ros Detection of Liver Metastases: Comparison of Gadobenate Dimeglumine-enhanced and Ferumoxides-enhanced MR Imaging Examinations Radiology, December 1, 2002; 225(3): 766 - 772. [Abstract] [Full Text] [PDF]

				G. N. Mann, H. F. Marx, L. L. Lai, and L. D. Wagman Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability Ann. Surg. Oncol., August 1, 2001; 8(7): 573 - 579. [Abstract] [Full Text] [PDF]

				T. Albrecht, C. W. Hoffmann, S. A. Schmitz, S. Schettler, A. Overberg, C. T. Germer, and K.-J. Wolf Phase-Inversion Sonography During the Liver-Specific Late Phase of Contrast Enhancement: Improved Detection of Liver Metastases Am. J. Roentgenol., May 1, 2001; 176(5): 1191 - 1198. [Abstract] [Full Text] [PDF]

				W. C. Black Anatomic Extent of Disease: A Critical Variable in Reports of Diagnostic Accuracy Radiology, November 1, 2000; 217(2): 319 - 320. [Full Text]

				R. A. Heckemann, D. O. Cosgrove, M. J. K. Blomley, R. J. Eckersley, C. J. Harvey, and Y. Mine Liver Lesions: Intermittent Second-Harmonic Gray-Scale US Can Increase Conspicuity with Microbubble Contrast Material-Early Experience Radiology, August 1, 2000; 216(2): 592 - 596. [Abstract] [Full Text]

				J. Petersein, A. Spinazzi, A. Giovagnoni, P. Soyer, F. Terrier, R. Lencioni, C. Bartolozzi, L. Grazioli, A. Chiesa, R. Manfredi, et al. Focal Liver Lesions: Evaluation of the Efficacy of Gadobenate Dimeglumine in MR Imaging-A Multicenter Phase III Clinical Study Radiology, June 1, 2000; 215(3): 727 - 736. [Abstract] [Full Text]

				S. S. Yoon and K. K. Tanabe Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases Oncologist, June 1, 1999; 4(3): 197 - 208. [Abstract] [Full Text]

				J. Ward, K. S. Naik, J. A. Guthrie, D. Wilson, and P. J. Robinson Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative–Free Response Receiver Operating Characteristic Analysis Radiology, February 1, 1999; 210(2): 459 - 466. [Abstract] [Full Text]